Observational study comparing the safety and tolerability of Somatuline (Registered trade mark) Autogel (Registered trade mark) injected by Health Care Professionals and patients who inject at home for the treatment of neuroendocrine tumours.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2009
This article has no abstract
Epistemonikos ID: 869bc413b77ba45886bcc982b328793f6c4f5c59
First added on: Feb 22, 2025